Michael Korenkov

Hematology & oncology trainee @ChariteBerlin | Member @lab_keller & @haas_lab | Formerly @FKlein_Lab @UKKoeln

[Blood Journals Portfolio @BloodPortfolio]

"BCMA-targeted T-cell engager therapy induces sustained remission in immune thrombocytopenia" read the study in Blood ICT: https://t.co/MzzrfPSq3L

[Nature Cancer @NatureCancer]

🌟Out today at Nature Cancer

Stromal cells and chemokine gradients organize the loss of tissue architecture in lymph nodes in B cell lymphoma

by Judith B. Zaugg, Daniel Hübschmann, Simon Haas & Sascha Dietrich & co
https://t.co/leRsBK9miC

[Charité - Universitätsmedizin Berlin @ChariteBerlin]

💡Möglicher neuer Ansatz gegen #Bauchspeicheldrüsenkrebs: Wie eine #CharitéBerlin-Studie jetzt zeigt, führt die gleichzeitige Blockade zweier voneinander abhängiger „Zahnrädchen“ in der Krebszelle zur Hemmung des Tumorwachstums – zumindest im Tiermodell.👉https://t.co/qCsiZyfVqs

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

CIDP as another (rare) MNT-style AE of cilta-cel in #MMsm.

Great correlatives in @BloodCancerJnl by 🇩🇪 group: TCRseq identified oligoclonal CARs (CDR epitopes similar to GBS) in one case.

Early treatment with high-dose Cy, IT chemo is key - now need preemptive ID & mitigation!

[Michael Korenkov @KorMichi]

This work was a joint project led by Antonia Busse @KroenkeLab @haas_lab and @lab_keller.
https://t.co/kVJtRO6Oh2
#CIDP #CART #Myeloma

[Michael Korenkov @KorMichi]

We report two cases of severe CIDP following cilta-cel therapy. Findings suggest bystander activation of CD8⁺ non-CAR-T cells rather than direct CAR-T toxicity. Timely T-cell–depleting therapy with cyclophosphamide may improve outcomes. Out now @BloodCancerJnl!

[Michael Korenkov @KorMichi]

Both cases will also be presented at the upcoming DGHO meeting in cologne during the poster session Multiple Myeloma I. Join us to discuss CAR-T–associated neurotoxicity and immune-mediated complications in myeloma. We look forward to seeing you there! @dgho_eV #DGHO2025

[Mostafa Faisal @MostafaFaisal14]

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy
@BloodCancerJnl
https://t.co/B4gnx0tfNx

[Keller-Lab@Charite @lab_keller]

Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus | New England Journal of Medicine https://t.co/K9n4nq8Rzn

[Immunity @ImmunityCP]

Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants https://t.co/dQryd8wT2G

[Uniklinik Köln @UKKoeln]

Wie verändert sich die Antikörperantwort gegen #SARSCoV2 mit der Zeit und wie bereitet sich das Immunsystem mit klugen Strategien auf neue Varianten vor? Die AG von Prof. Klein @FKlein_Lab hat dazu Studien in @ImmunityCP und @SciImmunology veröffentlicht. https://t.co/4KJnc9hNTJ

[Waggoner Lab @LabWaggoner]

pre-Omicron SARS-CoV-2-nAbs carry mutations that minimally impact activity vs. ancestral Wu01 strain, but become critical to neutralize Omicron BA.1/BA.2, thus SHM diversifies primary Ab response to deal with emerging variants @ImmunityCP
https://t.co/4k90f9LPCN

[Leif Erik Sander🇺🇦 @Sander_Lab]

@FKlein_Lab unstoppable.
Very cool work on how cross-neutralizing antibodies to SARS-COV-2 are made. Congratulations!

[Christoph Kreer @ChristophKreer]

This was a great journey with @KorMichi, @zehner_matthias and @DiskinLab, where we learned how bystander mutations help to prepare for viral escape by diversifying our antibody memory. Thankful for the opportunity to co-lead this project with @FKlein_Lab

[Science Immunology @SciImmunology]

New research finds that Omicron breakthrough infection following a third dose of #SARSCoV2 vaccination leads to selection of pre-existing “ultra-broad” memory B cells, which can neutralize many variants. @FKlein_Lab @UniCologne https://t.co/W9PUCtrDLv

[Michael Korenkov @KorMichi]

@ImmunityCP Very happy to have contributed to this work☺️ Follow @FKlein_Lab for highlights and a lot more awesome science! Special thanks to @ChristophKreer, @zehner_matthias, and the entire @FKlein_Lab team, as well as to our collaborators @DiskinLab!

[Michael Korenkov @KorMichi]

@ImmunityCP @ChristophKreer @matthias_zehner @FKlein_Lab @DiskinLab Of course I meant to thank @zehner_matthias!

[Michael Korenkov @KorMichi]

Very excited to share our paper out in @ImmunityCP! Huge thanks to @ChristophKreer, @matthias_zehner and the whole @FKlein_Lab as well as to our collaborators @DiskinLab! 🎉🥳

[Klein Lab @FKlein_Lab]

We are very happy to share our latest publication out in @ImmunityCP! Here we investigated how somatic hypermutation impacts SARS-CoV-2 neutralizing antibodies (https://t.co/ZGNwb8OkDQ).
Thanks a lot to our dear 🇮🇱 friends and collaborators @DiskinLab

[Immunity @ImmunityCP]

Online now: Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants https://t.co/hmwl9cc1N7

[Klein Lab @FKlein_Lab]

We are very happy to share our latest publication out in @ImmunityCP! Here we investigated how somatic hypermutation impacts SARS-CoV-2 neutralizing antibodies (https://t.co/ZGNwb8OkDQ).
Thanks a lot to our dear 🇮🇱 friends and collaborators @DiskinLab